700-bed University & 850-bed public medical center, multiple subspecialty clinics. HM3 LVAD implantation with continued support of HM II & HVAD. Single & multi-organ transplant, including extensive experience with end-stage complex congenital heart disease. 1yr/3yr post-transplant survival rates exceed national average. Transplant volumes in top 20% nationwide. Dedicated CICU and VA-ECMO program. Fellows exceed COCATS standards in hemodynamic studies, Level III CPET, and endomyocardial biopsy.